The SPAC’s first amendement to its prospectus includes details on private placements, the shareholder rights agreement and consent of counsel. Read more.
Dragoneer Amends $200M IPO
Related Posts
Churchill VII Says CorpAcq Deal Remains ‘On Track’
The deal has a pro forma enterprise value of approximately $1.58 billion.
Apex and AvePoint Announce Financial Results for FY 2020
The information was released in support of the companies' pending business combination.
GX to Restate Financials with New Accounting for Warrants
The SPAC is in a pending $372 million merger with Celularity, a clinical-stage biotechnology company.
AGBA Shareholders Approve 5th Deadline Extension
AGBA raised $40 million in a May 2019 IPO to focus on operating businesses in the healthcare, education, entertainment and financial services sectors that have their principal operations in China.